SG Americas Securities LLC Decreases Stock Holdings in The Clorox Company $CLX

by · The Markets Daily

SG Americas Securities LLC lowered its stake in The Clorox Company (NYSE:CLX – Free Report) by 5.1% during the first quarter, Holdings Channel.com reports. The fund owned 264,194 shares of the company’s stock after selling 14,151 shares during the quarter. SG Americas Securities LLC’s holdings in Clorox were worth $27,378,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Evolve Private Wealth LLC lifted its holdings in Clorox by 69.2% during the first quarter. Evolve Private Wealth LLC now owns 4,843 shares of the company’s stock valued at $502,000 after purchasing an additional 1,981 shares in the last quarter. Scott & Selber Inc. increased its stake in shares of Clorox by 47.2% during the first quarter. Scott & Selber Inc. now owns 24,839 shares of the company’s stock worth $2,574,000 after purchasing an additional 7,964 shares in the last quarter. First Community Trust NA raised its position in shares of Clorox by 5.6% during the 1st quarter. First Community Trust NA now owns 10,074 shares of the company’s stock worth $1,044,000 after purchasing an additional 533 shares during the last quarter. Davis Capital Management lifted its stake in Clorox by 75.5% in the 1st quarter. Davis Capital Management now owns 4,436 shares of the company’s stock valued at $460,000 after buying an additional 1,909 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S boosted its holdings in Clorox by 42.1% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 76,232 shares of the company’s stock worth $7,900,000 after buying an additional 22,567 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.63% of the company’s stock.

Clorox Trading Up 3.0%

Shares of CLX opened at $95.45 on Thursday. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03. The firm has a market capitalization of $11.54 billion, a P/E ratio of 15.50, a P/E/G ratio of 0.48 and a beta of 0.56. The firm has a 50-day moving average price of $94.96 and a 200 day moving average price of $104.54. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the business posted $1.45 EPS. Clorox’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts forecast that The Clorox Company will post 5.61 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. UBS Group lowered their price target on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Wells Fargo & Company lowered their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. Royal Bank Of Canada decreased their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Morgan Stanley lowered their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Finally, Weiss Ratings upgraded shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $103.40.

View Our Latest Stock Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).